2023
|
Invention
|
Treatments for diseases and disorders that involve oxidative stress.
Peptide compounds and their... |
|
Invention
|
Treatments for diseases and disorders that involve oxidative stress. Peptide compounds and their ... |
2022
|
Invention
|
Inhibition of tumor necrosis factor, pro-inflammatory cytokines and other inflammatory response m... |
2021
|
Invention
|
Treatments for improving or lessening impairment of mitochondrial function. Peptide therapies to ... |
|
Invention
|
Treatments for improving or lessening impairment of mitochondrial function.
Peptide therapies to... |
2020
|
Invention
|
Therapeutic and neuroprotective peptides.
Nonnatural peptides and their methods of use in human ... |
|
Invention
|
Peptides for treating non-exudative macular degeneration and other disorders of the eye.
Methods... |
|
Invention
|
Peptides for treating non-exudative macular degeneration and other disorders of the eye. Uses of ... |
|
Invention
|
Pharmaceutical compositions and preparations for administration to the eye. 3H)COOH) and derivati... |
|
Invention
|
Peptide therapies for reduction of macular thickening. 5-Integrin, inhibiting cellular adhesion t... |
2019
|
Invention
|
Peptides useable for treatment of disorders of the eye. 3H)COOH) and derivatives thereof, includi... |
2018
|
Invention
|
Therapeutic and neuroprotective peptides. Nonnatural peptides and their methods of use in human o... |
|
Invention
|
Peptides useable for treating cancer. 5-Integrin, inhibiting cellular adhesion to RGD binding sit... |
|
Invention
|
Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic ... |
2012
|
Invention
|
Integrin receptor antagonists and their methods of use. 5-Integrin, inhibiting cellular adhesion ... |
|
Invention
|
Integrin receptor antagonists and their methods of use. Compounds comprising R-G-Cysteic Acid (i.... |
2010
|
Invention
|
Peptide compositions and therapeutic uses thereof. 3H)COOH) and derivatives thereof, including ph... |